Completed PHASE4 INTERVENTIONAL 3-arm NCT05123170

Dexmedetomidine in IVRA

Comparison of Two Different Doses of Dexmedetomidine Added to Lignocaine in Patients Posted for Upper Limb Orthopedic Surgery Under Intravenous Regional Anaesthesia

Sponsor: Menoufia University

Conditions Regional Anesthesia Morbidity

Interventions Dexmedetomidine Injectable Solution [Dexdomitor] Lidocaine IV

Updated 5 times since 2021 Last updated: Jan 14, 2022 Started: Feb 28, 2020 Primary completion: Mar 25, 2021 Completion: Jun 20, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Regional Anesthesia Morbidity, this trial is completed. The trial is conducted by Menoufia University and has accumulated 5 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Feb 2022 — Jul 2024 [monthly]

Completed PHASE4
Dec 2021 — Feb 2022 [monthly]

Completed PHASE4

First recorded

Feb 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Menoufia University

Data source: Menoufia University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shibīn al Kawm, Egypt